These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 1375025

  • 41. [Platelet-activating factor (PAF) antagonists].
    Terasawa M.
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract] [Full Text] [Related]

  • 42. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
    Schattner M, Parini A, Fouque F, Vargaftig BB, Touqui L.
    Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
    da Silva MB, Herion F, Raskinet R, David JL, Gustin P, Dessy C, Lekeux P.
    Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726
    [Abstract] [Full Text] [Related]

  • 44. PLA2-induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action.
    Moreno JJ, Ferrer X, Ortega E, Carganico G.
    Agents Actions; 1992 Jul; 36(3-4):258-63. PubMed ID: 1382379
    [Abstract] [Full Text] [Related]

  • 45. BN52021 inhibits activation of peritoneal mast cells caused by hemorrhage and blood volume restoration.
    Debek W, Chyczewski L, Oldhafer KJ.
    Pol J Pathol; 1999 Jul; 50(4):259-67. PubMed ID: 10721266
    [Abstract] [Full Text] [Related]

  • 46. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z, Imura Y, Takatani M, Tsushima S, Nishikawa K.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [Abstract] [Full Text] [Related]

  • 47. Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea.
    Brunelleschi S, Renzi D, Ledda F, Giotti A, Fantozzi R, Brink C, Benveniste J.
    Br J Pharmacol; 1989 Jun; 97(2):469-74. PubMed ID: 2758225
    [Abstract] [Full Text] [Related]

  • 48. Inhibitory effect of MY-1250 on histamine release from rat peritoneal mast cells and guinea pig lung fragments: the elucidation of the mechanism.
    Kamei C, Mio M, Izushi K, Yoshii N, Fujisawa K, Tasaka K.
    Immunopharmacol Immunotoxicol; 1991 Jun; 13(3):341-56. PubMed ID: 1719061
    [Abstract] [Full Text] [Related]

  • 49. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
    Landucci EC, Antunes E, Donato JL, Faro R, Hyslop S, Marangoni S, Oliveira B, Cirino G, de Nucci G.
    Br J Pharmacol; 1995 Feb; 114(3):578-83. PubMed ID: 7537590
    [Abstract] [Full Text] [Related]

  • 50. [Effect of phospholipase A2 inhibitor on substance P-induced histamine release from rat peritoneal mast cells].
    Hisada T, Ishizuka T, Kurosawa M.
    Arerugi; 1991 May; 40(5):555-8. PubMed ID: 1715683
    [Abstract] [Full Text] [Related]

  • 51. Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists.
    Vásquez-Bravo YL, Russo M, Jancar S.
    J Lipid Mediat; 1993 Nov; 8(3):135-44. PubMed ID: 8268459
    [Abstract] [Full Text] [Related]

  • 52. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    J Lipid Mediat; 1991 Nov; 3(2):225-37. PubMed ID: 1797154
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Inhibition of histamine secretion from mast cells by lipoxygenase- and cyclooxygenase inhibitors.
    Grupe R, Ziska T.
    Agents Actions; 1994 Jun; 41 Spec No():C34-6. PubMed ID: 7526652
    [Abstract] [Full Text] [Related]

  • 59. Histamine potentiates human platelet aggregation induced by platelet-activating factor.
    Sipka S, Koltai M, Braquet P, Szegedi G.
    Int Arch Allergy Immunol; 1992 Jun; 97(1):89-92. PubMed ID: 1582704
    [Abstract] [Full Text] [Related]

  • 60. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM, Bernat A, Valette G, Gigo V, Lale A, LaPlace MC, Lespy L, Savi P, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.